Another application of RB-DCC was described targeting RNA-mediated myotonic dystrophy type 1 (DM1).119 In this example, RB-DCC was employed to screen the same extensive library against (CUG) repeat RNA, a hallmark of DM1 pathology. Here, DCC is linked to myotonic dystrophy type 1.